Phreesia (PHR) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SOPHiA GENETICS SA (SOPH) has outperformed Phreesia (PHR) over the past year, gaining 62.9% versus a loss of 54.2%. Over five years, SOPH leads with a -54.7% price change compared with -83.3% for PHR. Phreesia is the larger company by market cap ($661.7 million vs $621.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PHR | SOPH |
|---|---|---|
| Share price | $10.66 | $7.30 |
| Market cap | $661.68M | $621.43M |
| 1-day change | +1.52% | +2.10% |
| YTD return | -37.00% | +56.32% |
| 1-year return | -54.15% | +62.95% |
| 5-year return | -83.25% | -54.66% |
| P/E ratio (TTM) | 62.71 | — |
| Forward P/E | 6.74 | — |
| EPS (TTM) | $0.17 | $-1.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.25 | $8.98 |
| 52-week low | $7.77 | $3.75 |
| Distance from 52-week high | -56.03% | -18.71% |
| Analyst consensus | buy | none |
| Avg. price target upside | +31.99% | +33.56% |
| Average volume | 741.28K | 547.82K |
| Shares outstanding | 62.07M | 85.13M |
| Employees | 1,789 | 415 |
| Sector | Consumer Discretionary | Technology |
| Industry | Business Services | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SOPH has outperformed PHR by 117.1 percentage points over the past year.
- The two companies sit in different sectors: Phreesia in Consumer Discretionary and SOPHiA GENETICS SA in Technology.
About Phreesia
PHR stock →Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Consumer Discretionary · Business Services · 1,789 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Technology · EDP Services · 415 employees
PHR vs SOPH FAQ
Which is bigger, Phreesia or SOPHiA GENETICS SA?
Phreesia (PHR) is larger, with a market capitalization of $661.68M compared with $621.43M for SOPHiA GENETICS SA (SOPH).
Which stock has performed better over the past year, PHR or SOPH?
SOPH returned +62.95% over the past 12 months, compared with -54.15% for PHR (price return, excluding dividends). Past performance does not predict future results.
Are Phreesia and SOPHiA GENETICS SA in the same industry?
No. Phreesia is in the Consumer Discretionary sector, while SOPHiA GENETICS SA is in Technology.